CN210542870U

CN210542870U - Transdermal drug delivery therapeutic apparatus

Info

Publication number: CN210542870U
Application number: CN201821308225.3U
Authority: CN
Inventors: 王红; 陈静; 王中正
Original assignee: Qingdao Unique Products Develop Co ltd
Current assignee: Guangzhou Youni Zhikang Biotechnology Co ltd
Priority date: 2017-06-14
Filing date: 2017-06-14
Publication date: 2020-05-19
Anticipated expiration: 2027-06-14
Also published as: CN210698487U; CN207886521U; CN210698488U

Abstract

The utility model discloses a transdermal drug delivery therapeutic apparatus, which comprises a main controller and a therapeutic handle; the treatment handle comprises a handle and a treatment head; the therapeutic head comprises an ultrasonic transducer, an electromagnetic coil and a pulse electrode; the ultrasonic transducer is embedded in the center of the treatment head, and the electromagnetic coil is embedded in the treatment head and positioned at the periphery of the ultrasonic transducer; the pulse electrode is embedded in the therapeutic head and is positioned at the periphery of the electromagnetic coil; the handle is provided with a handle treatment mode switching key and a handle function key which are connected with the main controller. The treatment head simultaneously comprises an ultrasonic transducer, an electromagnetic coil and a pulse electrode, and based on the drug administration principle of percutaneous drug administration, the treatment head acts on the surface of the skin to be administered in a single or multiple combined working modes by switching the treatment mode switching keys, so that the permeation effect of certain specific drugs for treating the autism is improved, and the technical problem of single drug administration mode of the existing autism is solved.

Description

Transdermal drug delivery therapeutic apparatus

The application is a divisional application of a Chinese utility model patent application 201720688992.0 entitled "transdermal drug delivery therapeutic apparatus" proposed in 2017, 06, 14.

Technical Field

The utility model belongs to the technical field of medical equipment, specifically speaking relates to a transdermal therapeutic instrument of dosing.

Background

Autism is a developmental behavior disorder disease characterized mainly by social interaction/communication disorders of different degrees, narrow interests, repetitive stereotypy behaviors, and sensory abnormalities, and seriously affects the quality of life of patients and their families.

In recent years, with the rapid development of the medical field, patients with autism have more choices in the administration mode. However, the traditional administration methods such as oral administration and injection cannot meet the administration requirements of patients with autism for certain specific drugs due to certain characteristics.

Disclosure of Invention

The application provides a transdermal therapeutic instrument that doses solves current autism and doses the single technical problem of mode.

In order to solve the technical problems, the application adopts the following technical scheme:

provides a transdermal drug delivery therapeutic apparatus, which comprises a main controller and a therapeutic handle; the treatment handle comprises a handle and a treatment head; the treatment head comprises an ultrasonic transducer, an electromagnetic coil and a pulse electrode; the ultrasonic transducer is embedded in the center of the treatment head, and the electromagnetic coil is embedded in the treatment head and positioned at the periphery of the ultrasonic transducer; the pulse electrode is embedded in the treatment head and is positioned at the periphery of the electromagnetic coil; the handle is provided with a handle treatment mode switching key and a handle function key which are connected with the main controller.

Furthermore, the handle function keys comprise a treatment time setting key and a treatment intensity adjusting key.

Further, the surfaces of the ultrasonic transducer, the electromagnetic coil and the pulse electrode are flush with the surface of the treatment head.

Furthermore, a main control treatment mode switching key and a main control function key are installed on the main controller; the main control treatment mode switching key is connected with the handle treatment mode switching key in parallel; the main control function key is connected with the handle function key in parallel.

Further, the shell of the ultrasonic transducer is made of stainless steel materials.

Further, the electromagnetic coil is an annular Helmholtz coil.

Furthermore, the main controller is also provided with a display module and/or an alarm.

Compared with the prior art, the application has the advantages and positive effects that: the transdermal drug delivery therapeutic apparatus provided by the application comprises an ultrasonic transducer, an electromagnetic coil and a pulse electrode in a therapeutic head, and based on the drug administration principle of transdermal drug delivery, the transdermal drug delivery therapeutic apparatus acts on the surface of the skin for drug administration in a single or multiple combined working modes by switching of the therapeutic mode switching key, so that the permeation effect of certain specific drugs for treating autism is improved, and the technical problem of single drug administration mode of the existing autism is solved.

Other features and advantages of the present application will become more apparent from the detailed description of the embodiments of the present application when taken in conjunction with the accompanying drawings.

Drawings

FIG. 1 is a block diagram of a transdermal therapeutic device according to the present application;

fig. 2 is a functional architecture diagram of the main controller of the transdermal therapeutic apparatus according to the present application.

Detailed Description

The following describes embodiments of the present application in further detail with reference to the accompanying drawings.

The application provides a transdermal drug delivery therapeutic apparatus, as shown in figure 1, comprising a main controller 1 and a therapeutic handle; the treatment handle comprises a handle 21 and a treatment head 22; the treatment head comprises an ultrasonic transducer 221, an electromagnetic coil 222 and a pulse electrode 223; the ultrasonic transducer 221 is embedded in the center of the treatment head 22, and the electromagnetic coil 222 is embedded in the treatment head 22 and located at the periphery of the ultrasonic transducer 221; the pulse electrode 223 is embedded in the treatment head 22 and is positioned at the periphery of the electromagnetic coil 222; a handle treatment mode switching button 211 and a handle function button 212 connected to the main controller via a cable 3 are mounted on the handle 21.

When the ultrasonic transducer acts on human skin, the structure of stratum corneum lipid can be changed, so that the drugs can be absorbed through skin, and the longer the duration is, the more drugs can permeate into the skin. When the magnetic field generated by the electromagnetic coil acts on the skin of a human body, the current distribution of the human body, the movement of charge particles, the permeability of a membrane system and the magnetic moment orientation of biological macromolecules are influenced, so that the physiological and biochemical processes of tissue cells are changed, the effects of easing pain, reducing swelling, promoting blood and lymph circulation and the like are generated, the percutaneous absorption of ionizable medicines can be promoted, and the medicines are pushed into the dermis and the subcutaneous skin for treatment. The pulse electrode acts on the skin based on instantaneous high-voltage pulse, reversible temporary water channels are opened in lipid bilayers of skin stratum corneum cells, the transdermal drug delivery rate can be accelerated, the skin is not damaged, and the effect is quick.

When the transdermal drug delivery therapeutic apparatus is used for transdermal drug delivery treatment of patients with autism, any one of three transdermal drug delivery modes on a therapeutic head can be selected to act on the skin by operating a handle treatment mode switching key, the treatment effect of transdermal drug delivery is achieved, if the effect of a single treatment mode on transdermal drug delivery is not high or obvious, any two or three combinations of three scalp drug delivery modes can be switched and selected to act on the surface of the skin to be applied according to the application characteristics and the treatment requirements, the ultrasonic waves, the electromagnetic fields and the electric pulses are massaged and stimulated at the same acupuncture points, blood vessels are expanded, blood flow is accelerated, the permeability of blood vessels is improved, the drug delivery speed is improved, and the curative effect is further improved.

By operating the handle function keys, the handle function keys include but are not limited to a treatment time setting key and a treatment intensity adjusting key, and the treatment time and the intensity of the electric pulse or the electromagnetic field can be adjusted according to the autism treatment prescriptions of different autism patients.

Therefore, the transdermal drug delivery therapeutic apparatus provided by the application combines the ultrasonic transducer, the electromagnetic coil and the pulse electrode, and acts on the skin surface applied with drugs in a single or multiple combined working modes by switching the treatment mode switching key based on the drug application principle of transdermal drug delivery, so that the permeation effect of certain specific drugs for treating autism is improved, and the technical problem of single drug application mode of the existing autism is solved.

As shown in FIG. 1, the surfaces of the ultrasound transducer 221, the electromagnetic coil 222 and the pulse electrode 223 are all flush with the surface of the treatment head. A main control treatment mode switching key 11 and a main control function key 12 are arranged on the main controller 1; the main control treatment mode switching key 11 is connected with the handle treatment mode switching key 211 in parallel; the master control function key 12 is connected in parallel with the handle function key 212; the user can operate the keys on the handle to realize mode switching and adjustment of treatment intensity and time, and can also operate the keys on the main controller to realize mode switching and adjustment of treatment intensity and time.

The shell of the ultrasonic transducer 221 is made of stainless steel materials, the frequency range of emitted ultrasonic waves is 40KHZ-1MHZ, the excitation peak voltage is 100V, ultrasonic waves are output intermittently, and the output period of each group of ultrasonic waves is 0-200 ms.

The electromagnetic coil 222 is an annular Helmholtz coil, and the field strength adjustment range is 0-50 mT.

The pulse width of the instantaneous high-voltage pulse output by the pulse electrode 223 is adjustable from 6us to 150us, and the no-load voltage peak value is 85V to 100V; the low-voltage pulse (low-voltage sine wave or square wave pulse group) output by the pulse electrode 223 has the pulse width of 1us-1000us and the no-load voltage peak value of 36v or 24 v.

As shown in fig. 2, the main controller 1 includes two working modules, i.e., a microprocessor U1, a power supply module U2, two pulse transformers U3 and U4, an ultrasonic generator U5, and a magnetic field generator U6, where the U3 is used to generate an instantaneous high-voltage pulse, the U4 is used to generate a low-voltage pulse, and the switching output of the high-voltage pulse and the low-voltage pulse is realized by a switching circuit U7, and specific working principles are not described herein. The main controller 1 provided by the application is also provided with a display module U8 and/or an alarm U9; the display module U8 can be used to display the information of treatment mode, treatment time, treatment intensity, etc., and the alarm U9 can be used to sound an alarm when the treatment time is over, or an over-current protection sound alarm, etc.

The therapeutic instrument that collection ultrasonic transducer, solenoid and pulse electrode that this application provided are very integrative improves the drug permeation effect of autism transdermal drug delivery treatment, has improved autism treatment curative effect and convenient operation.

It should be noted that the above description is not intended to limit the present invention, and the present invention is not limited to the above examples, and the changes, modifications, additions or substitutions made by those skilled in the art within the spirit of the present invention should also belong to the protection scope of the present invention.

Claims

1. The transdermal drug delivery therapeutic apparatus is characterized by comprising a main controller and a therapeutic handle;

the treatment handle comprises a handle and a treatment head; the treatment head comprises an ultrasonic transducer, an electromagnetic coil and a pulse electrode; the ultrasonic transducer is embedded in the center of the treatment head, and the electromagnetic coil is embedded in the treatment head and positioned at the periphery of the ultrasonic transducer; the pulse electrode is embedded in the treatment head and is positioned at the periphery of the electromagnetic coil; the pulse electrode outputs instantaneous high-voltage pulse or low-voltage pulse, and switching output is realized through a switching circuit;

the handle is provided with a handle treatment mode switching key and a handle function key which are connected with the main controller;

the main controller is provided with a main control treatment mode switching key and a main control function key; the main control treatment mode switching key is connected with the handle treatment mode switching key in parallel; the main control function key is connected with the handle function key in parallel.

2. The transdermal drug delivery therapeutic apparatus according to claim 1, wherein the handle function buttons include a treatment time setting button and a treatment intensity adjusting button.

3. The transdermal drug delivery therapeutic apparatus of claim 1, wherein the surfaces of the ultrasound transducer, the electromagnetic coil and the pulse electrode are flush with the surface of the treatment head.

4. The transdermal therapeutic apparatus of claim 1, wherein the housing of the ultrasonic transducer is made of stainless steel.

5. The transdermal drug delivery therapeutic apparatus of claim 1, wherein the electromagnetic coil is an annular Helmholtz coil.